会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 28. 发明申请
    • MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF
    • GLUCOCORTICOID受体的调节剂,AP-1和/或NF-κB活性及其用途
    • WO2008021926A2
    • 2008-02-21
    • PCT/US2007/075543
    • 2007-08-09
    • BRISTOL-MYERS SQUIBB COMPANYWEINSTEIN, David, S.GONG, HuaDUAN, JingwuDHAR, T.G. MuraliYANG, Bingwei VeraCHEN, PingJIANG, Bin
    • WEINSTEIN, David, S.GONG, HuaDUAN, JingwuDHAR, T.G. MuraliYANG, Bingwei VeraCHEN, PingJIANG, Bin
    • C07D417/12C07D277/46C07D405/12C07D417/14C07D491/04
    • Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-KB activity, including inflammatory and immune diseases, having the structure of formula (I), an enantiomer, diastereomer, or tautomer thereof, or a prodrug ester thereof, or a pharmaceutically-acceptable salt thereof, in which: Z is heterocyclo or heteroaryl; A is a 5- to 8- membered carbocyclic ring or a 5- to 8-membered heterocyclic ring; B is a cycloalkyl, cycloalkenyl, aryl, heterocyclo, or heteroaryl ring, wherein each ring is fused to the A ring on adjacent atoms and optionally substituted by one to four groups which are the same or different and are independently selected from R 5 , R 6 , R 7 , and R 8 ; J 1 , J 2 , and J3 are at each occurrence the same or different and are independently -A 1 QA 2 -; Q is a bond, O, S, S(O), or S(O)2; A 1 and A 2 are the same or different and are at each occurrence independently selected from a bond, C1-3alkylene, substituted C 1 - 3 alkylene, C 2 -4alkenylene, and substituted C 2 - 4 alkenylene, provided that A 1 and A 2 are chosen so that ring A is a 5- to 8-membered carbocyclic or heterocyclic ring; R 1 to R 11 are as defined herein. Also provided are pharmaceutical compositions and methods of treating inflammatory- or immune-associated diseases and obesity and diabetes employing said compounds.
    • 提供了新的非甾体化合物,其可用于治疗与式(I)结构的糖皮质激素受体,AP-1和/或NF-κB活性(包括炎症和免疫疾病)的调节相关的疾病,对映异构体 ,非对映体或其互变异构体,或其前药酯或其药学上可接受的盐,其中:Z是杂环或杂芳基; A是5-至8-元碳环或5-至8-元杂环; B是环烷基,环烯基,芳基,杂环或杂芳基环,其中每个环与相邻原子上的A环稠合,并且任选地被一至四个相同或不同的基团取代,并且独立地选自R 1, R 5,R 6,R 7和R 8; J 1,J 2和J 3在每次出现时相同或不同,并且独立地为-A 1 N 2 QA 2, SUB> - ; Q是键,O,S,S(O)或S(O)2; A 1和A 2各自相同或不同,并且在每次出现时独立地选自键,C 1-3亚烷基,取代的C 1 H 3,